RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
New York, NY · +20 more sites
Breast Cancer clinical trials in New York, NY
83 recruiting breast cancer studies with a site in New York, NY.
RecruitingPhase 3NCT07391774
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Sponsor: National Cancer Institute (NCI)
Brooklyn, NY · Buffalo, NY · East Hills, NY · +200 more sites
RecruitingPhase 3NCT06841354
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Sponsor: Merck Sharp & Dohme LLC
Mineola, NY · New York, NY · +37 more sites
RecruitingPhase 1NCT07310420
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Sponsor: TerSera Therapeutics LLC
Amsterdam, NY · New York, NY · The Bronx, NY · +23 more sites
RecruitingPhase 3NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sponsor: Eli Lilly and Company
Albany, NY · Brooklyn, NY · New York, NY · +126 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
New York, NY · +14 more sites
RecruitingPhase 3NCT06790693
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Sponsor: Hoffmann-La Roche
New York, NY · +59 more sites
RecruitingNot applicableNCT06037954
A Study of Mental Health Care in People With Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
New York, NY
RecruitingPhase 1NCT06840886
A Study of PHST001 in Advanced Solid Tumors
Sponsor: Pheast Therapeutics
Lake Success, NY · New York, NY · +18 more sites
RecruitingPhase 3NCT06982521
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Sponsor: Relay Therapeutics, Inc.
New York, NY · +49 more sites
RecruitingPhase 1NCT07454642
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Sponsor: Avacta Life Sciences Ltd
New York, NY · +6 more sites
RecruitingPhase 2NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor: Daiichi Sankyo
Buffalo, NY · New York, NY · +11 more sites
RecruitingPhase 1NCT05877599
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Sponsor: AstraZeneca
New York, NY · +19 more sites
RecruitingPhase not listedNCT06094257
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
Sponsor: Weill Medical College of Cornell University
New York, NY · +1 more sites
RecruitingNot applicableNCT07214532
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Sponsor: Natera, Inc.
Babylon, NY · New York, NY · Rochester, NY · +46 more sites
RecruitingNot applicableNCT07711847
Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy
Sponsor: HeroSupport SA
New York, NY
RecruitingPhase 1NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Sponsor: SystImmune Inc.
New York, NY · +21 more sites
RecruitingPhase 1NCT07020117
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Sponsor: Aktis Oncology, Inc.
New York, NY · +12 more sites
RecruitingPhase 1 / Phase 2NCT05898399
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
Sponsor: Artios Pharma Ltd
New York, NY · +6 more sites
RecruitingPhase 3NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sponsor: Stemline Therapeutics, Inc.
Brooklyn, NY · East Syracuse, NY · Ithaca, NY · +173 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
New York, NY · +32 more sites
RecruitingNot applicableNCT07391956
Tier Palliative Care For Patients With Advanced Heart Failure or Cancer
Sponsor: Icahn School of Medicine at Mount Sinai
Astoria, NY · New York, NY · +2 more sites
RecruitingPhase 1 / Phase 2NCT05130801
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
Sponsor: Memorial Sloan Kettering Cancer Center
New York, NY · +1 more sites
RecruitingPhase 1 / Phase 2NCT06657222
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Sponsor: Gilead Sciences
New York, NY · +12 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Bay Shore, NY · Bronxville, NY · Brooklyn, NY · +1223 more sites
RecruitingPhase 3NCT06072612
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Sponsor: BriaCell Therapeutics Corporation
Babylon, NY · Manhattan, NY · New Hyde Park, NY · +76 more sites
RecruitingPhase 1NCT06458712
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Sponsor: Duke Street Bio Ltd
New York, NY · +3 more sites
RecruitingPhase 1NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Sponsor: Nammi Therapeutics Inc
New York, NY · Rochester, NY · +8 more sites
RecruitingPhase 2NCT07459673
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +4 more sites
RecruitingPhase 2NCT07776613
A Study of Romosozumab in People With Breast Cancer and Osteoporosis
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +4 more sites
RecruitingPhase not listedNCT06888388
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
New York, NY · Rochester, NY · +3 more sites
RecruitingPhase 1 / Phase 2NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Sponsor: Bristol-Myers Squibb
New York, NY · +9 more sites
RecruitingPhase 3NCT05232916
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Sponsor: Greenwich LifeSciences, Inc.
Albany, NY · New York, NY · Stony Brook, NY · +48 more sites
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Bay Shore, NY · Brooklyn, NY · +825 more sites
RecruitingPhase 1 / Phase 2NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Sponsor: Daiichi Sankyo
New York, NY · Westbury, NY · +15 more sites
RecruitingPhase 3NCT06748222
E-Mindfulness Approaches for Living After Breast Cancer
Sponsor: NRG Oncology
Astoria, NY · Glens Falls, NY · Middletown, NY · +378 more sites
RecruitingNot applicableNCT07225309
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
New York, NY
RecruitingNot applicableNCT07646847
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +5 more sites
RecruitingPhase 1NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Sponsor: MOMA Therapeutics
New York, NY · +10 more sites
RecruitingNot applicableNCT07723209
Radiation After No Axillary Nodal Sampling
Sponsor: NYU Langone Health
New York, NY
RecruitingPhase 1NCT07318805
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Sponsor: Pfizer
Long Island City, NY · New York, NY · +10 more sites
RecruitingNot applicableNCT05592938
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Sponsor: University Health Network, Toronto
New York, NY · +1 more sites
RecruitingPhase 2NCT05467891
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Sponsor: Oana Danciu
New York, NY · +20 more sites
RecruitingNot applicableNCT05585788
Opioid Dispensing Device for Post-Operative Pain in Cancer Patients
Sponsor: Columbia University
New York, NY
RecruitingPhase 2NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Sponsor: Jazz Pharmaceuticals
New York, NY · +16 more sites
RecruitingNot applicableNCT07335354
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +6 more sites
RecruitingPhase 1 / Phase 2NCT05768139
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Sponsor: Eli Lilly and Company
New York, NY · +27 more sites
RecruitingPhase 1NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Babylon, NY · Brooklyn, NY · New Hyde Park, NY · +103 more sites
RecruitingPhase not listedNCT05438511
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
Sponsor: Memorial Sloan Kettering Cancer Center
New York, NY
RecruitingPhase 1NCT07046923
A Study of LY4175408 in Participants With Advanced Cancer
Sponsor: Eli Lilly and Company
New York, NY · +13 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.